Bcl-2 expression in malignant melanoma and its prognostic significance

European Journal of Surgical Oncology

Volumn 22, Issue 4, 1996, Pages 347-349

  Grover, R ^a   Wilson, G D ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Melanoma; Oncogene

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOMA; MULTIVARIATE ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

EID: 0029748608     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)90176-6     Document Type: Article

References (14)

1. Pezzella F, Ralfkiaer E, Gatter KC, Mason DY. The 14; 18 translocation in European cases of follicular lymphoma: comparison of southern blotting and the polymerase chain reaction. Br J Haematol 1990; 76: 58-64.
2. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
3. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-6.
4. Pezzella F, Gatter K. What is the value of bcl-2 detection for histopathologists? Histopathology 1995; 26: 89-93.
5. Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
6. Cox DR. Regression model and life tables. J Royal Stat Soc 1972; 34: 187-220.
7. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ (eds) Cutaneous Melanoma (2nd edn). Philadelphia: J. B. Lippincott Co., 1992: 165-87.
8. Pezzella F, Turley H, Kuzu I, et al. Bcl-2 protein in non-small cell lung carcinoma. W Engl J Med 1993; 329: 690-4.
9. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole ?, Nunez G. Expression of the apoptosis suppressing protein bcl-2 in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 1993; 143: 1543-50.
10. Cerroni L, Soyer HP, Kerl H. Bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic naevi. Am J Dermatopathol 1995; 17: 7-11.
11. Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC. Immunohistochemical analysis of bcl-2 protein regulation in cutaneous melanoma. Am J Pathol 1995; 146: 643-50.
12. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
13. Lane DP. The regulation of p53 function. Int J Cancer 1994; 57: 623-7.
14. Pezzella F, Gatter KC, Mason DY. Bcl-2 protein expression in follicular lymphoma in the absence of 14;18 translocation. Lancet 1990; 336: 1510-11.